Merck (MRK) Total Non-Current Liabilities (2016 - 2025)
Merck (MRK) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $76.6 billion as the latest value for Q4 2025.
- Quarterly Total Non-Current Liabilities changed N/A to $76.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $76.6 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $76.6 billion for FY2025, N/A changed from the prior year.
- Total Non-Current Liabilities for Q4 2025 was $76.6 billion at Merck, up from $70.0 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $76.6 billion in Q4 2025, with the low at $300.0 million in Q1 2021.
- Average Total Non-Current Liabilities over 5 years is $18.3 billion, with a median of $600.0 million recorded in 2022.
- The sharpest move saw Total Non-Current Liabilities changed 0.0% in 2021, then surged 8090.93% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $300.0 million in 2021, then soared by 100.0% to $600.0 million in 2022, then grew by 25.0% to $750.0 million in 2023, then changed by 0.0% to $750.0 million in 2024, then surged by 10109.6% to $76.6 billion in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $76.6 billion, $70.0 billion, and $61.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.